معرفی
Kevin Sevarino, MD is a Clinical Associate Professor in the Department of Psychiatry at Yale School of Medicine. His primary affiliation is with Yale University, where he contributes to both clinical care and research in addiction medicine. Dr. Sevarino completed his MD at McGill University in 1982.
His research focuses on substance use disorders, particularly stimulant and alcohol dependence. Key areas include pharmacological interventions (e.g., mecamylamine, naltrexone), contingency management strategies, and dual diagnosis treatment approaches. He has authored/co-authored over 50 peer-reviewed publications since 2000, including seminal works on cocaine dependence treatment and smoking cessation during alcohol recovery.
Notable contributions include a 2017 randomized controlled trial evaluating mecamylamine for alcohol dependence and a 2015 study on concurrent alcohol-tobacco treatment effects. His work frequently involves collaborations with researchers like John Krystal, Ned Cooney, and Erin O'Brien.
Dr. Sevarino has participated in translational research initiatives exploring novel pharmacotherapies and behavioral interventions. His recent publications (2023-2024) update clinical guidelines on stimulant use disorders.